QCLGX | VIGAX | QCLGX / VIGAX | |
Total Expense Ratio | 1.75 | 0.05 | 3,500% |
Annual Report Gross Expense Ratio | 1.88 | 0.05 | 3,760% |
Fund Existence | 20 years | 25 years | - |
Gain YTD | 8.394 | 7.727 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 3000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.07B | 294B | 1% |
Annual Yield % from dividends | 0.00 | 0.45 | - |
Returns for 1 year | 12.01 | 15.43 | 78% |
Returns for 3 years | 59.88 | 96.41 | 62% |
Returns for 5 years | 32.84 | 115.36 | 28% |
Returns for 10 years | 65.80 | 312.86 | 21% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BFTHX | 62.31 | 1.01 | +1.65% |
Baron Fifth Avenue Growth Retail | |||
PIOTX | 24.50 | 0.15 | +0.62% |
Victory Pioneer Core Equity A | |||
PEUCX | 40.20 | 0.19 | +0.47% |
Principal Equity Income C | |||
NIECX | 18.26 | 0.05 | +0.27% |
BNY Mellon International Equity C | |||
LYFIX | 12.32 | -0.01 | -0.08% |
AlphaCentric Life Sciences & Hlthcare I |